Profile
Martin E.
Sanders is the founder of Seurat Therapeutics, Inc., Io Therapeutics, Inc. Former positions include President & Chief Executive Officer at Palingen, Inc. (US) from 2004 to 2008 and Chief Development Officer & EVP at Dynavax Technologies Corp.
in 2008.
Education includes an undergraduate degree from the University of Missouri and a doctorate from The University of Chicago.
Martin E. Sanders active positions
| Companies | Position | Start |
|---|---|---|
Seurat Therapeutics, Inc.
Seurat Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates pre-clinical biotechnology company that develops nasal sprays to alleviate and prevent future migraines | Founder | - |
Io Therapeutics, Inc.
Io Therapeutics, Inc. BiotechnologyHealth Technology Develops retinoid and rexinoid molecule drugs for treatment of cancer | Chief Executive Officer | 2010-12-31 |
Former positions of Martin E. Sanders
| Companies | Position | End |
|---|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Corporate Officer/Principal | 2008-10-31 |
Palingen, Inc. (US) | President | 2007-12-31 |
Training of Martin E. Sanders
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Dynavax Technologies Corp.
Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
Io Therapeutics, Inc.
Io Therapeutics, Inc. BiotechnologyHealth Technology Develops retinoid and rexinoid molecule drugs for treatment of cancer | Health Technology |
University of Missouri
University of Missouri Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Palingen, Inc. (US) | |
Seurat Therapeutics, Inc.
Seurat Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates pre-clinical biotechnology company that develops nasal sprays to alleviate and prevent future migraines | Commercial Services |
- Stock Market
- Insiders
- Martin E. Sanders
















